Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
RESEARCH TOOLSreports
Technical Sentiment
Overall Consensus
Neutral
7Bullish
6Neutral
9Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Adaptimmune Therapeutics’s (ADAP) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (ADAP) 20-Day exponential moving average is 0.28, while Adaptimmune Therapeutics’s (ADAP) share price is $0.29, making it a Buy.
Adaptimmune Therapeutics’s (ADAP) 50-Day exponential moving average is 0.33, while Adaptimmune Therapeutics’s (ADAP) share price is $0.29, making it a Sell.
Adaptimmune Therapeutics (ADAP) Pivot Points
Classic
0.29
0.29
0.30
0.30
0.31
0.31
0.32
Fibonacci
0.29
0.30
0.30
0.30
0.31
0.31
0.31
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Adaptimmune Therapeutics (ADAP) Moving Averages
MA5
0.30Sell
0.29Sell
MA10
0.29Buy
0.29Buy
MA20
0.27Buy
0.28Buy
MA50
0.32Sell
0.33Sell
MA100
0.45Sell
0.45Sell
MA200
0.69Sell
0.66Sell
Adaptimmune Therapeutics’s (ADAP) 10-Day exponential moving average is 0.29, while Adaptimmune Therapeutics’s (ADAP) share price is $0.29, making it a Buy.
Adaptimmune Therapeutics’s (ADAP) 100-Day exponential moving average is 0.45, while Adaptimmune Therapeutics’s (ADAP) share price is $0.29, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.29 and Adaptimmune Therapeutics’s (ADAP) 50-day simple moving average is 0.32, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.29 and Adaptimmune Therapeutics’s (ADAP) 100-day simple moving average is 0.45, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.29 and Adaptimmune Therapeutics’s (ADAP) 200-day simple moving average is 0.69, creating a Sell signal.
Adaptimmune Therapeutics (ADAP) Technical Indicators
RSI (14)
50.65
Neutral
STOCH (9,6)
66.14
Neutral
STOCHRSI (14)
73.21
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
22.52
Neutral
Williams %R
-35.90
Buy
CCI (14)
96.07
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
36.30
Neutral
ROC
20.83
Buy
Adaptimmune Therapeutics’s (ADAP) Relative Strength Index (RSI) is 50.65, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Trend Strength Indicator (ADX) is 22.52, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Commodity Channel Index (CCI) is 96.07, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Price Rate of Change (ROC) is 20.83, creating a Buy signal.
FAQ
Is ADAP a Buy, Hold, or Sell?
Based on ADAP’s technical indicators, ADAP is a Hold.
What is ADAP’s RSI (14)?
ADAP’s RSI (14) is 50.65, which suggests ADAP is a Neutral.
What is ADAP’s MACD?
ADAP’s MACD is >-0.01, which suggests ADAP is a Sell.
What is ADAP’s 5-day moving average?
ADAP’s 5-day moving average is 0.30, which suggests ADAP is a Sell.
What is ADAP’s 20-day moving average?
ADAP 20-day moving average is 0.27, which suggests ADAP is a Buy.
What is ADAP’s 50-day moving average?
ADAP’s 50-day moving average is 0.32, which suggests ADAP is a Sell.
What is ADAP’s 200-day moving average?
ADAP’s 200-day moving average is 0.69, which suggests ADAP is a Sell.
What is ADAP’s Williams % R (14)?
ADAP’s Williams % R (14) is -35.90, which suggests ADAP is a Buy.
What is ADAP’s CCI (14)?
ADAP’s CCI (14) is 96.07, which suggests ADAP is a Neutral.